1 min read

Gramer et al (2003) J Cytotechnology

From the Hawaii Biotech archive: (1) BioVest International, Inc., 8500 Evergreen Boulevard, Minneapolis, MN, 55433, USA (2) Hawaii Biotech, Inc, 99-193 Aiea Heights Dr., Suite 200 Aiea, HI 96701, USA
Gramer et al (2003) J Cytotechnology

Hi, Biotech is an independent publication with no affiliation with Hawaii Biotech, Inc. This page preserves a historical record from the company's original press archive, republished for research and archival purposes. Copyright in the original material remains with its original owner.

Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell MAb medium

Michael J. Gramer1, Jodi Maas1 and Michael M. Lieberman2

(1) BioVest International, Inc., 8500 Evergreen Boulevard, Minneapolis, MN, 55433, USA (2) Hawaii Biotech, Inc, 99-193 Aiea Heights Dr., Suite 200 Aiea, HI 96701, USA

Journal Cytotechnology: Volume 42, Number 3 / September, 2003 Pages 155-162

Abstract The combination of BD Cell MAb medium with the CL-1000 flask is increasingly being used to generate a few hundred milli gram of antibody for early stage research projects. Cells are inoculated at 2 million per ml, and the antibody is harvested after 15 days or when the antibody concentrati on reaches above 10 mg ml −1, whichever comes first. Currently, there is no means to scale up beyond this production level using this technology. In this study, we evaluated hollow fiber technology as the scale up alternative. The hollow fiber system was ru n in batch mode to mimic the method used for the CL-1000 with BD MAb medium. T he FL-NS murine hybridoma cell line was simultaneously inoculated at 2 million cells per ml in a CL-1000 and the Maximizer hollow fiber bioreactor system, a 21-fold theoretical scale up over the CL-1000. The Maximizer produced 23-fold more antibody, very close to the expected theoretical amount. However, production was complete after 9 days in the Maximizer, while the CL- 1000 required the full 15 days for production. In summary, these results demonstrate successful scale up of antibody production from the CL-1000 to a hollow fiber system. Antibody - CL-1000 - Hollow fiber bioreactor - Hybridoma - Scale up

This revised version was published online in July 2006 with corrections to the Cover Date.